AAAAAA
Results:
1-14
|
Results: 14
Authors:
Kern, W
Beckert, B
Lang, N
Stemmler, J
Beykirch, M
Stein, J
Goecke, E
Waggershauser, T
Braess, J
Schalhorn, A
Hiddemann, W
Citation: W. Kern et al., Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer, ANN ONCOL, 12(5), 2001, pp. 599-603
Authors:
Lang, NK
Schalhorn, A
Hiddemann, W
Citation: Nk. Lang et al., Case study - Osteogenesis imperfecta, Type 1, INTERNIST, 42(8), 2001, pp. 1151-1155
Authors:
Holdenrieder, S
Stieber, P
Bodenmuller, H
Busch, M
Fertig, G
Furst, H
Schalhorn, A
Schmeller, N
Untch, M
Seidel, D
Citation: S. Holdenrieder et al., Nucleosomes in serum of patients with benign and malignant diseases. (vol 95, pg 114, 2001), INT J CANC, 95(6), 2001, pp. 398-398
Authors:
Holdenrieder, S
Stieber, P
Bodenmuller, H
Busch, M
Fertig, G
Furst, H
Schalhorn, A
Schmeller, N
Untch, M
Seidel, D
Citation: S. Holdenrieder et al., Nucleosomes in serum of patients with benign and malignant diseases, INT J CANC, 95(2), 2001, pp. 114-120
Authors:
Heinemann, V
Wilke, H
Mergenthaler, HG
Clemens, M
Konig, H
Illiger, HJ
Arning, M
Schalhorn, A
Possinger, K
Fink, U
Citation: V. Heinemann et al., Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer, ANN ONCOL, 11(11), 2000, pp. 1399-1403
Authors:
Kern, W
Beckert, B
Lang, N
Waggershauser, T
Braess, J
Schalhorn, A
Hiddemann, W
Citation: W. Kern et al., Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: Role of carcino-embryonic antigen in assessment of response, ANTICANC R, 20(6D), 2000, pp. 4973-4975
Authors:
Forstpointner, R
Braunschweig, R
Meissner, H
Lang, N
Kuhl, M
Schalhorn, A
Citation: R. Forstpointner et al., Embolization in an adrenocortical carcinoma as palliative therapy, ONKOLOGIE, 22(6), 1999, pp. 513-516
Authors:
Hasholzner, U
Stieber, P
Zimmermann, A
Burges, A
Hofmann, K
Schmitt, UM
Schmeller, N
Schalhorn, A
Citation: U. Hasholzner et al., Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases, ANTICANC R, 19(4A), 1999, pp. 2415-2420
Authors:
Heinemann, V
Schermuly, MM
Stieber, P
Schulz, L
Jungst, D
Wilkowski, R
Schalhorn, A
Citation: V. Heinemann et al., CA19-9: A pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin, ANTICANC R, 19(4A), 1999, pp. 2433-2435
Authors:
Hasholzner, U
Stieber, P
Reiter, W
Zimmermann, A
Hofmann, K
Schalhorn, A
Citation: U. Hasholzner et al., CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer, ANTICANC R, 19(4A), 1999, pp. 2477-2480
Authors:
Stieber, P
Dienemann, H
Schalhorn, A
Schmitt, UM
Reinmiedl, J
Hofmann, K
Yamaguchi, K
Citation: P. Stieber et al., Pro-gastrin-releasing peptide (ProGRP) - A useful marker in small cell lung carcinomas, ANTICANC R, 19(4A), 1999, pp. 2673-2678
Authors:
Holdenrieder, S
Stieber, P
Forg, T
Kuhl, M
Schulz, L
Busch, M
Schalhorn, A
Seidel, D
Citation: S. Holdenrieder et al., Apoptosis in serum of patients with solid tumours, ANTICANC R, 19(4A), 1999, pp. 2721-2724
Authors:
Waggershauser, T
Herrmann, K
Schalhorn, A
Reiser, M
Citation: T. Waggershauser et al., Percutaneous implantation of port-catheter systems for intraarterial chemotherapy of the liver, RADIOLOGE, 39(9), 1999, pp. 772-776
Authors:
Engel, J
Feldmann, HJ
Bayerl, A
Rohloff, R
Skulina, E
Sauer, H
Schalhorn, A
Jauch, KW
Citation: J. Engel et al., Medical report content recommendations on rectal carcinoma. Part III: Report on radiotherapy and final report of a chemotherapy, ZBL CHIR, 123(12), 1998, pp. 1436-1438
Risultati:
1-14
|